Application of an inline dry powder inhaler to deliver high dose pharmaceutical aerosols during low flow nasal cannula therapy
- 5 May 2018
- journal article
- research article
- Published by Elsevier in International Journal of Pharmaceutics
- Vol. 546 (1-2) , 1-9
Abstract
No abstract availableKeywords
Funding Information
- Eunice Kennedy Shriver National Institute of Child Health & Human Development of the National Institutes of Health
- National Heart, Lung and Blood Institute of the National Institutes of Health
This publication has 44 references indexed in Scilit:
- Aerodynamic Factors Responsible for the Deaggregation of Carrier-Free Drug Powders to Form Micrometer and Submicrometer AerosolsPharmaceutical Research, 2013
- Inhalation Therapy in Patients Receiving Mechanical Ventilation: An UpdateJournal of Aerosol Medicine and Pulmonary Drug Delivery, 2012
- Deposition of Dry Powder Generated by Solovent in Sophia Anatomical Infant Nose-Throat (SAINT) ModelAerosol Science and Technology, 2012
- Condensational Growth of Combination Drug-Excipient Submicrometer Particles for Targeted High Efficiency Pulmonary Delivery: Comparison of CFD Predictions with Experimental ResultsPharmaceutical Research, 2011
- Improving the Lung Delivery of Nasally Administered Aerosols During Noninvasive Ventilation—An Application of Enhanced Condensational Growth (ECG)Journal of Aerosol Medicine and Pulmonary Drug Delivery, 2011
- Numerical Model to Characterize the Size Increase of Combination Drug and Hygroscopic Excipient Nanoparticle AerosolsAerosol Science and Technology, 2011
- Electrostatics of pharmaceutical inhalation aerosolsJournal of Pharmacy and Pharmacology, 2009
- Electrostatics of pharmaceutical inhalation aerosolsJournal of Pharmacy and Pharmacology, 2009
- Aerosol Delivery through Nasal Cannulas: An In Vitro StudyJournal of Aerosol Medicine and Pulmonary Drug Delivery, 2008
- In vitro assessment of drug delivery through an endotracheal tube using a dry powder inhaler delivery system.Thorax, 1996